The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 16, 2021
Filed:
Dec. 28, 2018
Applicant:
Vyne Pharmaceuticals Ltd., Rehovot, IL;
Inventors:
Dov Tamarkin, Maccabim, IL;
Elana Gazal, Rehovot, IL;
Irakliy Papiashvili, Ashkelon, IL;
Yohan Hazot, Rehovot, IL;
David Schuz, Gimzu, IL;
Rita Keynan, Rehovot, IL;
Assignee:
Vyne Therapeutics Inc., Bridgewater, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/31 (2006.01); A61K 8/34 (2006.01); A61K 8/36 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 31/137 (2006.01); A61K 31/192 (2006.01); A61K 31/4164 (2006.01); A61K 31/57 (2006.01); A61K 31/573 (2006.01); A61K 31/593 (2006.01); A61K 31/65 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01); A61K 47/44 (2017.01); A61Q 17/04 (2006.01); A61Q 19/00 (2006.01); A61Q 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 47/44 (2013.01); A61K 8/31 (2013.01); A61K 8/342 (2013.01); A61K 8/361 (2013.01); A61K 9/0014 (2013.01); A61K 9/0048 (2013.01); A61K 9/12 (2013.01); A61K 9/122 (2013.01); A61K 9/124 (2013.01); A61K 31/137 (2013.01); A61K 31/192 (2013.01); A61K 31/4164 (2013.01); A61K 31/57 (2013.01); A61K 31/573 (2013.01); A61K 31/593 (2013.01); A61K 31/65 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/24 (2013.01); A61Q 17/04 (2013.01); A61Q 19/00 (2013.01); A61Q 19/10 (2013.01); A61K 2800/31 (2013.01); A61K 2800/33 (2013.01);
Abstract
A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition.